EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Long-term endocrine and reproductive outcomes in female adolescent and young adult survivors after hematopoietic stem cell transplantation for hematological malignancies during childhood or adolescence

Weronika Zajączkowska, Katarzyna Derwich, Cezary Miedziarek, Agnieszka Sobkowiak-Sobierajska, Zofia Kolesińska, Maria Buda, Witold Kędzia, Karina Kapczuk

Frontiers in Endocrinology · 2026

DOI: 10.3389/fendo.2026.1921689 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Endocrinology, 2026. Verfasst von Weronika Zajączkowska und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gynecology, Poznan University of Medical Sciences, Poznan, Poland. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Primary Ovarian Insufficiency, Hematologic Neoplasms, Cancer Survivors. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cancer treatment during childhood and adolescence, particularly hematopoietic stem cell transplantation (HSCT), may adversely affect long-term reproductive and endocrine health in female adolescent and young adult (AYA) survivors, leading to premature ovarian insufficiency (POI), which may be associated with impaired pubertal development, low bone mass, and reproductive complications.

Methods

This study included 34 female survivors treated with HSCT for hematological malignancies during childhood or adolescence (median age 10.8 years). The median follow-up from HSCT to the last gynecological assessment was 8.5 years. Hormonal assessment, pelvic ultrasound, and bone mineral density (BMD) evaluation were performed. Patients were classified as having normal ovarian function, transient ovarian insufficiency (TOI), or persistent POI.

Results

At the last follow-up, normal ovarian function was observed in 15 patients (44.1%), TOI in 7 (20.6%), and persistent POI in 12 (35.3%). Patients with normal ovarian function were significantly older at HSCT (p = 0.0432), whereas premenarchal status was associated with impaired ovarian outcome (p = 0.0066). In multivariable analysis including cyclophosphamide equivalent dose (CED), radiotherapy, and menarchal status at HSCT, postmenarchal status was associated with markedly lower odds of ovarian insufficiency (adjusted OR 0.056, 95% CI 0.005–0.566; p = 0.0147). All postmenarchal patients received GnRHa, precluding separation of the effects of menarchal status and GnRHa exposure; GnRHa-treated survivors had higher AMH concentrations (p =0.0032). AMH and FSH concentrations differed significantly between groups (both p < 0.01). Uterine and mean ovarian volumes, antral follicle count (AFC), and BMD were significantly lower in patients with TOI and POI (all p < 0.05). Radiotherapy exposure was associated with both lower uterine and ovarian volumes, while puberty induction was also associated with lower uterine volume (all p <0.05). Two patients diagnosed with POI achieved spontaneous pregnancies during follow-up, one resulting in a live birth.

Conclusions

Ovarian dysfunction is highly prevalent after childhood HSCT, although partial recovery of ovarian function may occur even in patients with a diagnosis of POI. Persistent POI is associated with impaired uterine development and lower BMD despite ongoing hormone replacement therapy, underscoring the need for timely and long-lasting individualized endocrine and reproductive care in AYA survivors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationPrimary Ovarian InsufficiencyHematologic NeoplasmsCancer SurvivorsReproductionHumansFemaleAdolescentYoung AdultChildFollow-Up StudiesAdultOvarySurvivorsBone Density

Stichwörter der Autor:innen

bone mineral density (BMD)childhood cancer survivors (CCS)fertility preservation and restoration for cancer patientsgonadotropin releasing hormone (GnRH) agonisthematopoietic stem cell transplantation (HSCT)ovarian reserve (OR)premature ovarian insufficiency (POI)transient ovarian insufficiency (TOI)

Autor:innen und Institutionen

  • Division of Gynecology, Poznan University of Medical Sciences, Poznan, Poland.
  • Doctoral School, Poznan University of Medical Sciences, Poznan, Poland.
  • Department of Pediatric Oncology, Hematology and Transplantology, Institute of Pediatrics, Poznan University of Medical Sciences, Poznan, Poland.
  • Division of Gynecological Oncology, Department of Gynecology, Poznan University of Medical Sciences, Poznan, Poland.
  • Department of Pediatric Endocrinology and Rheumatology, Poznan University of Medical Sciences, Poznan, Poland.
  • Division of Gynecology, Unit of Pediatric and Adolescent Gynecology, Poznan University of Medical Sciences, Poznan, Poland.

Zitieren

APA

Zajączkowska, W., Derwich, K., Miedziarek, C., Sobkowiak-Sobierajska, A., Kolesińska, Z., Buda, M., Kędzia, W., & Kapczuk, K. (2026). Long-term endocrine and reproductive outcomes in female adolescent and young adult survivors after hematopoietic stem cell transplantation for hematological malignancies during childhood or adolescence. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2026.1921689

Vancouver

Zajączkowska W, Derwich K, Miedziarek C, Sobkowiak-Sobierajska A, Kolesińska Z, Buda M, et al. Long-term endocrine and reproductive outcomes in female adolescent and young adult survivors after hematopoietic stem cell transplantation for hematological malignancies during childhood or adolescence. Frontiers in Endocrinology. 2026. doi:10.3389/fendo.2026.1921689

BibTeX
@article{Zajczkowska2026,
  author = {Zajączkowska, Weronika and Derwich, Katarzyna and Miedziarek, Cezary and Sobkowiak-Sobierajska, Agnieszka and Kolesińska, Zofia and Buda, Maria and Kędzia, Witold and Kapczuk, Karina},
  title = {Long-term endocrine and reproductive outcomes in female adolescent and young adult survivors after hematopoietic stem cell transplantation for hematological malignancies during childhood or adolescence},
  journal = {Frontiers in Endocrinology},
  year = {2026},
  doi = {10.3389/fendo.2026.1921689}
}
Kostenlos starten →